National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

4-hydroxytamoxifen
A tamoxifen metabolite with both estrogenic and anti-estrogenic effects. 4-hydroxytamoxifen has a higher affinity for the estrogen receptor than tamoxifen, and functions as an antagonist in breast cancer cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:4-Hydroxy-Tamoxifen



Previous:2-methoxyestradiol, 3'-deoxy-3'-[18F]fluorothymidine, 3,4-methylenedioxymethamphetamine, 3-deazauridine, 4'-iodo-4'-deoxydoxorubicin
Next:4-nitroestrone 3-methyl ether, 5,10-methylenetetrahydrofolate, 5-[18F]fluorouracil, 5-hydroxytryptophan, 50% oxygen/50% nitrous oxide premix

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov